MetaVia to Present Data Highlighting DA-1726, a GLP-1/Glucagon Dual Agonist, in a Late-Breaking Poster Presentation at the EASL Congress 2026

Go back to MetaVia to Present Data Highlighting DA-1726, a GLP-1/Glucagon Dual Agonist, in a Late-Breaking Poster Presentation at the EASL Congress 2026
(NASDAQ: MTVA) Delayed: 1.74 -0.27 (13.43%)
Previous Close $2.01    52 Week High
Open $1.88    52 Week Low
Day High $2.17    P/E N/A 
Day Low $1.72    EPS
Volume 592,813